Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

No treatment has been found which reverses long-standing neurological dysfunction in patients with multiple sclerosis (MS). Observations in animal models of MS show that immunoglobulins directed against CNS components promote oligodendroglial proliferation and new myelin synthesis. Preliminary studi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurol Neurosurg Psychiatry
Autors principals: Noseworthy, J H, O'Brien, P C, van Engelen, B G, Rodriguez, M
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 1994
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1016715/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7964842/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.57.suppl.11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars